Protagonist Therapeutics, Inc. (PTGX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$91.14
Day's range
$97.54

Protagonist Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 9.78 M $1.03 B   0.65% 15.38%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 6.35 M $669.17 M   3.34% 9.99%
UBS GROUP AG 05/05/2026 5.18 M $545.74 M   86.92% 8.14%
RTW INVESTMENTS, LP 05/15/2026 5.06 M $533.22 M   0.00% 7.96%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.60 M $379.40 M   13.50% 5.66%
05/15/2026 3.48 M $366.92 M   100.00% 5.48%
STATE STREET CORP 05/15/2026 3.12 M $328.51 M   -2.59% 4.90%
JANUS HENDERSON GROUP PLC 05/18/2026 2.89 M $304.87 M   9.12% 4.55%
05/15/2026 2.81 M $295.74 M   100.00% 4.41%
JOHNSON & JOHNSON 05/13/2026 2.45 M $258.14 M   0.00% 3.85%
INVESCO LTD. 05/12/2026 2.16 M $228.16 M   38.07% 3.41%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.67 M $175.98 M   14.90% 2.63%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.67 M $175.55 M   18.90% 2.62%
CITADEL ADVISORS LLC 05/15/2026 1.55 M $163.57 M   37.74% 2.44%
WOODLINE PARTNERS LP 05/15/2026 1.41 M $149.05 M   0.38% 2.22%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.30 M $136.54 M   49.32% 2.04%
PERCEPTIVE ADVISORS LLC 05/29/2026 1.23 M $129.73 M   -8.85% 1.94%
JENNISON ASSOCIATES LLC 05/06/2026 1.07 M $112.99 M   223.71% 1.69%
MORGAN STANLEY 05/15/2026 1.02 M $107.32 M   15.84% 1.60%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 994.12 K $104.78 M   -5.25% 1.56%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 829.29 K $87.41 M   100.00% 1.30%
GOLDMAN SACHS GROUP INC 05/15/2026 778.95 K $82.10 M   -18.96% 1.23%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 720.93 K $75.99 M   -34.41% 1.13%
FMR LLC 05/15/2026 662.00 K $69.77 M   22.62% 1.04%
MARSHALL WACE, LLP 05/15/2026 628.08 K $66.20 M   -38.72% 0.99%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 621.82 K $65.54 M   26.94% 0.98%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 593.20 K $62.52 M   197.31% 0.93%
NORTHERN TRUST CORP 05/14/2026 587.97 K $61.97 M   2.23% 0.92%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 581.08 K $61.25 M   9.71% 0.91%
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. 05/12/2026 571.83 K $60.27 M   0.00% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 552.96 K $58.28 M   -0.68% 0.87%
AMERICAN CENTURY COMPANIES INC 05/15/2026 537.32 K $56.63 M   0.35% 0.85%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 508.10 K $53.54 M   22.61% 0.80%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 454.38 K $47.89 M   24.09% 0.71%
RUBRIC CAPITAL MANAGEMENT LP 05/15/2026 428.00 K $45.11 M   100.00% 0.67%
VANGUARD FIDUCIARY TRUST CO 05/15/2026 412.73 K $43.50 M   100.00% 0.65%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 367.82 K $38.77 M   5.72% 0.58%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 355.00 K $37.42 M   -6.74% 0.56%
BANK OF NEW YORK MELLON CORP 05/05/2026 341.47 K $35.99 M   -2.55% 0.54%
VESTAL POINT CAPITAL, LP 05/15/2026 326.16 K $34.38 M   100.00% 0.51%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2026 306.04 K $32.26 M   -7.49% 0.48%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 282.44 K $29.77 M   21.30% 0.44%
05/07/2026 232.42 K $24.50 M   100.00% 0.37%
05/14/2026 229.62 K $24.20 M   0.00% 0.36%
SEGALL BRYANT & HAMILL, LLC 05/22/2026 212.71 K $22.42 M   64.82% 0.33%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/13/2026 210.28 K $22.16 M   3.37% 0.33%
HOLOCENE ADVISORS, LP 05/15/2026 209.92 K $22.13 M   -0.05% 0.33%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 194.53 K $20.50 M   98.98% 0.31%
TD ASSET MANAGEMENT INC 05/11/2026 183.70 K $19.36 M   15.73% 0.29%
EAGLE HEALTH INVESTMENTS LP 05/15/2026 179.32 K $18.90 M   212.95% 0.28%

Protagonist Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 394 institutional investors and hedge funds held shares of Protagonist Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 9.78 M

FARALLON CAPITAL MANAGEMENT LLC: 6.35 M

UBS Group AG: 5.18 M

RTW INVESTMENTS, LP: 5.06 M

WELLINGTON MANAGEMENT GROUP LLP: 3.6 M

STATE STREET CORP: 3.12 M

123.87% of Protagonist Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 88.71 M shares in the last 24 months. This purchase volume represents approximately $8.58 B in transactions.